Publications by authors named "J Cadranel"

Claim this Profile
R
Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study.
Thomas Pierret, Laurent Greillier, Florian Guisier, Catherine Daniel, Renaud Descourt, Jacques Cadranel

Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT features of interstitial lung disease in systemic lupus erythematosus and overlap lupus-other connective tissue disease.
Aurore Sajust de Bergues de Escalup, Arthur Mageau, Lou Deneuville, Karim Sacre, Antoine Khalil, Jacques Cadranel

Eur Radiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV.
Sophie Grabar, Paula Lakrout, Valérie Potard, Aurélien Belot, Jacques Cadranel

Int J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary toxicity of immune-checkpoint inhibitors.
Cédric Mahiat, Jacques Cadranel, Vincent Fallet, Constance Meteye, Sébastien Gendarme

Presse Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome.
Clémence David, Nadia Nathan, Eslam Al-Abadi, Peter D Arkwright, Brigitte Bader-Meunier, Jacques Cadranel

Ann Rheum Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis